Breaking news on arthritis
Pain Relief For Osteoarthritis Provided By Electromagnetic Pulses published
Mon, 08 Mar 2010 02:00:00 PST
Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers...
NICE Asks For More Data On New Drug For Rheumatoid Arthritis published
Thu, 04 Mar 2010 19:00:00 PST
NICE's independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product...
NICE Reassessment Of Switching Decision Brings Little Hope For Rheumatoid Arthritis Patients published
Thu, 04 Mar 2010 02:00:00 PST
The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE's provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS's successful appeal of negative NICE guidance on switching in 2007...
New 'Work Charter' Launched To Help 6.5m People With Musculoskeletal Conditions To Stay In Work, UK published
Thu, 04 Mar 2010 02:00:00 PST
Today the Arthritis and Musculoskeletal Alliance (ARMA), backed by leading policymakers and employers, is calling for positive action to ensure people with musculoskeletal disorders (MSDs) are properly supported to access employment and remain in their jobs...
NICE Consults On Draft Recommendations For Treating Rheumatoid Arthritis After Treatment With A TNF Inhibitor Has Failed published
Thu, 04 Mar 2010 00:00:00 PST
The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 and 141...
Rheumatologists Have Plenty Of Choice Among Biologic Agents For RA - Where Will Actemra Find Its Niche? published
Wed, 03 Mar 2010 04:00:00 PST
BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February...
Celiac Disease: Pinpointing Immune System Disturbances published
Tue, 02 Mar 2010 04:00:00 PST
New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified...
SSRIs Offer Model For Drug Development Opportunities To Treat Rheumatoid Arthritis published
Fri, 26 Feb 2010 06:00:00 PST
A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D...
Obesity And Physical Inactivity Poses Arthritis Risk, Especially For Women published
Fri, 26 Feb 2010 03:00:00 PST
Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women...
New NICE Guidance Set To Help People With Rheumatoid Arthritis published
Wed, 24 Feb 2010 22:00:00 PST
Final guidance published today (Wednesday 24 February 2010) by the National Institute for Health and Clinical Excellence (NICE) means that another drug - certolizumab pegol (Cimzia) - can be considered for some people in England and Wales suffering with rheumatoid arthritis...
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression Of Rheumatoid Arthritis published
Tue, 23 Feb 2010 01:00:00 PST
CEL-SCI Corporation (NYSE CVM) and their scientific collaborators announced that the Company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model...
What Is Enbrel (Etanercept)? What Is Enbrel Used For? published
Tue, 23 Feb 2010 00:00:00 PST
Enbrel is the trade name for Etanercept, a medication used for treating autoimmune diseases. Enbrel is a TNF (tumor necrosis factor) inhibitor; it interferes with TNF...
Award Supports Excellence In Musculoskeletal And Rheumatic Disease Education published
Sat, 20 Feb 2010 01:00:00 PST
At the core of the American College of Rheumatology Research and Education Foundation's mission is to attract the best and brightest trainees into a career in rheumatology. To do this, the REF has an extensive portfolio of awards and grants that provide support during critical career stages...
Contrast-Enhanced MRI Could Play A Key Role In Differentiating Between Common Types Of Arthritis published
Fri, 19 Feb 2010 03:00:00 PST
Contrast-enhanced magnetic resonance imaging (MRI) may help physicians differentiate between rheumatoid arthritis and psoriatic arthritis in the hand and wrist enabling more targeted therapies unique to each condition, according to a study in the March issue of the American Journal of Roentgenology . Contrast-enhanced MRI uses contrast media to improve the visibility of internal bodily structures...
Walking Linked To Eased Osteoarthritis published
Tue, 16 Feb 2010 01:00:00 PST
"Progressive walking" combined with glucosamine sulphate supplementation has been shown to improve the symptoms of osteoarthritis...
Differences In Orthopedic Surgical Outcomes Revealed By Medicare Data published
Mon, 15 Feb 2010 02:00:00 PST
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients. Among more specialized hospitals, there were fewer serious post-surgical complications such as blood clots, infections and heart problems, as well as fewer deaths...
Animal Models That Help Translate Regenerative Therapies From Bench To Bedside published
Sat, 13 Feb 2010 00:00:00 PST
Clinical testing and development of novel therapies based on advances in tissue engineering and regenerative medicine that will one day enable the repair and replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models...
Group Psychotherapy May Improve Fears In Patients With Cancer Or Chronic Arthritis published
Wed, 10 Feb 2010 02:00:00 PST
A controlled study by a group of German investigators published in the current issue of Psychotherapy and Psychosomatics indicates that brief group psychotherapy is helpful for clearing fears of disease progression (FoP) in patients with chronic arthritis or cancer. The interventions comprised either cognitive-behavioral group therapy or supportive-experiential group therapy...
HSS Supports Arthritis Foundation Focus On Raising National Awareness Of Osteoarthritis published
Fri, 05 Feb 2010 02:00:00 PST
Hospital for Special Surgery, (HSS), a world leader in orthopedics and rheumatology, announced its support of the Arthritis Foundation and Ad Council newly launched campaign, "Moving is the Best Medicine," to raise awareness of osteoarthritis, increase public health education and support breakthrough research...
Designing Easy-To-Use Products With The Help Of Arthritis Simulation Gloves published
Fri, 05 Feb 2010 00:00:00 PST
As the U.S. population ages, manufacturers of consumer goods are realizing that many customers may not be as nimble-fingered or sharp-sighted as they once were...
Can Blood Samples Predict Arthritic Rheumatism? published
Thu, 04 Feb 2010 02:00:00 PST
Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism...
FDA Approves Xiaflex For Debilitating Hand Condition published
Wed, 03 Feb 2010 03:00:00 PST
The U.S. Food and Drug Administration approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers. Dupuytren's contracture affects the connective tissue found beneath the skin in the palm of the hand...
New Nanoscopic Material Enables Cartilage To Do What It Doesn't Do Naturally published
Tue, 02 Feb 2010 05:00:00 PST
Northwestern University researchers are the first to design a bioactive nanomaterial that promotes the growth of new cartilage in vivo and without the use of expensive growth factors. Minimally invasive, the therapy activates the bone marrow stem cells and produces natural cartilage. No conventional therapy can do this. The results will be published online the week of Feb...
Arthritis Genes Discovered By University Of Queensland Scientists, Australia published
Tue, 02 Feb 2010 04:00:00 PST
University of Queensland researchers have been part of a major breakthrough in understanding the cause of the debilitating arthritic condition ankylosing spondylitis (AS)...
Dogs May Provide An Excellent Model For Understanding Human Complex Diseases published
Tue, 02 Feb 2010 02:00:00 PST
In the new Swedish-Finnish study, published in Nature Genetics, the researchers identified five loci that predispose to an SLE-related disease in Nova Scotia duck tolling retrievers. The study indicates that the homogeneity of strong genetic risk factors within dog breeds make dogs an excellent model in which to identify pathways involved in human complex diseases...
)
|
|
